abstract |
The invention relates to pharmaceutical compositions and combinations containing regorafenib and acetylsalicylic acid or their hydrate, solvate, metabolite or pharmaceutically acceptable salt or polymorph thereof for the treatment, prevention or control of diseases and conditions, including hyperproliferative disorders such as human cancer and other mammals. |